Latest Pharmaceuticals News
FDA approves two Scientia Vascular neurovascular catheters
Catheters approved by the FDA include the Plato 17, a DMSO-compatible microcatheter,…
Mark Cuban’s Cost Plus Pharmaceutical Company partners with RxLink
RxLink will incorporate Cost Plus pricing into its drug pricing platform MedMap.
AstraZeneca completes equity investment and research collaboration with Cellectis
The joint venture aims to develop up to 10 new cell and…
Evaluation of LP-284 using RADR for NHL and other targeted cancers
In this pharmaceutical executive video interview, Panna Sharma, CEO of Lantern Pharma,…
Future-proof your consulting career into 2024 and beyond
Q&A with Harvard Business School Healthcare Alumni Association and Columbia Business School…
Erleada’s Phase II Apa-RP trial showed promise in treating high-risk localized prostate cancer patients who previously underwent radical prostatectomy
Key findings include a 100% 24-month postoperative biochemical recurrence-free rate in patients…
